Cargando…
Guiding model‐driven combination dose selection using multi‐objective synergy optimization
Despite the growing appreciation that the future of cancer treatment lies in combination therapies, finding the right drugs to combine and the optimal way to combine them remains a nontrivial task. Herein, we introduce the Multi‐Objective Optimization of Combination Synergy – Dose Selection (MOOCS‐D...
Autores principales: | Gevertz, Jana L., Kareva, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681518/ https://www.ncbi.nlm.nih.gov/pubmed/37415306 http://dx.doi.org/10.1002/psp4.12997 |
Ejemplares similares
-
Pretomanid dose selection for pulmonary tuberculosis: An application of multi‐objective optimization to dosage regimen design
por: Lyons, Michael A.
Publicado: (2021) -
Bispecific antibodies: A guide to model informed drug discovery and development
por: Kareva, Irina, et al.
Publicado: (2021) -
Data-driven multi-objective optimization for electric vehicle charging infrastructure
por: Farhadi, Farzaneh, et al.
Publicado: (2023) -
Computational Modeling of Tumor Response to Vascular-Targeting Therapies—Part I: Validation
por: Gevertz, Jana L.
Publicado: (2011) -
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
por: Ianevski, Aleksandr, et al.
Publicado: (2020)